Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy.

Wells, Philip S; Gebel, Martin; Prins, Martin H; Davidson, Bruce L; Lensing, Anthonie Wa

Wells, Philip S; Gebel, Martin; Prins, Martin H; Davidson, Bruce L; Lensing, Anthonie Wa.

Afiliação

Wells PS; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.
Gebel M; Bayer HealthCare, Wuppertal, Germany.
Prins MH; Maastricht University Medical Center, Maastricht, The Netherlands.
Davidson BL; University of Washington School of Medicine, Seattle, WA USA.
Lensing AW; Bayer HealthCare, Wuppertal, Germany.

Thromb J ; 12: 26, 2014.

Article em En | MEDLINE | ID: mdl-25698905

Palavras-chave

Anticoagulant therapy; Rivaroxaban; Statins; Venous thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google